Key Facts and Data Points

  • Magnetic nanorobots: Helical, micron‑sized devices coated with iron‑oxide/silica, steered by external magnetic fields.
  • Applications: Targeted drug delivery, hyper‑thermia therapy, imaging‑guided surgery, biosensing, dental root‑canal treatment.
  • Awards: New York Academy of Sciences 2025 award & Tata Sons’ Transformation Prize.
  • Nanotechnology in healthcare:
  • Targeted carriers (liposomes, dendrimers, polymeric nanoparticles).
  • Enhanced diagnostics (gold nanoparticles, quantum dots).
  • Regenerative medicine (nanofiber scaffolds, stem‑cell delivery).
  • Antimicrobial coatings (Ag, Cu, ZnO nanoparticles).
  • Vaccine platforms (mRNA‑based nanocarriers).

Background and Context

  • Nanotechnology deals with structures ≤100 nm, where quantum effects dominate.
  • Magnetic actuation eliminates the need for onboard power, allowing navigation through blood vessels and tissue matrices.
  • India’s research ecosystem: IISc, IITs, CSIR labs, and the National Mission on Nanoscience and Technology (NMNT) provide funding and policy support.

Significance for India / Governance / Policy

  • Healthcare impact: Potential to reduce cancer mortality, improve treatment of neurological disorders, and lower healthcare costs in the long run.
  • Economic relevance: High‑value nanomedicine market could generate export earnings and create skilled jobs.
  • Regulatory challenges: Existing frameworks like the Drugs and Cosmetics Act, 1940, and CDSCO lack specific provisions for nanomaterials, leading to a regulatory vacuum.
  • Ethical & social concerns:
  • Nanotoxicity and bio‑accumulation risks.
  • Nano‑divide: inequitable access to advanced therapies.
  • Data privacy for implantable nanosensors.
  • Policy recommendations:
  1. Formulate dedicated Nanomedicine Guidelines under CDSCO.
  2. Mandate Environmental Impact Assessment (EIA) for nanomaterial production.
  3. Promote Green Nanotechnology and “safety‑by‑design”.
  4. Encourage public‑private partnerships for scaling up production.

Related Constitutional / Legal Provisions

  • Article 21 – Right to health as part of the right to life; state duty to ensure safe medical technologies.
  • National Health Policy 2017 – Emphasises adoption of emerging technologies for affordable healthcare.
  • Science, Technology and Innovation (STI) Policy 2022 – Calls for responsible innovation, ethical oversight, and inclusive access.

Bibliography / Further Reading

  • Ministry of Health & Family Welfare, Guidelines on Nanomedicines (draft, 2025).
  • CSIR‑NMNT Annual Report 2024‑25.
  • WHO Guidelines on Nanomaterials in Health Products (2023).